of all drugs are
While ~100 antibodies are approved
for various indications, only 1 antibody
is approved for CNS disease.
of an injected dose of a
therapeutic antibody is
delivered to the brain
50-fold increase in brain delivery of antibody’s injected dose, with 8x the payload.
Our proprietary technology platform’s Plug & Play approach opens the doors to infinite possibilities to create novel therapeutics with optimal modalities and mechanisms of action, for the treatment of brain cancers and CNS diseases.
Lab & Headquarters
3 Pinhas Sapir Street
Weizmann Science Park , IL